Market Strategy & Commercial Development
Market strategy and commercial development guide decisions throughout ATMP development to ensure that the therapy addresses a clear medical need and can be successfully adopted within healthcare systems. This includes evaluating the competitive landscape, engaging key stakeholders, developing commercial partnerships, and planning for future market access and growth. The goal is to create a pathway that supports both patient benefit and long-term commercial sustainability.
OligoNova
OligoNova is a Swedish national center and research network with the mission to transform brilliant academic research into groundbreaking medicines for unmet patient need. This is achieved within the OligoNova Hub, part of the SciLifeLab Drug Discovery and Development (DDD) platform, by offering industry-standard drug discovery infrastructure and expertise to academic researchers across Sweden.
CO-AX Accelerator
A startup accelerator that helps identify, develop, and scale innovative health technology. They offer tailored support and industry connections founders need to turn health innovation ideas into real world impact.
Workshop: Secure the right competencies to your SME
Do you want to ensure that your company has the right skills for the future? Strengthen your organization’s skills and capabilities through a workshop tailored to your needs. The content can be adapted to your company’s specific challenges, priorities, and development goals.
AstraZeneca
AstraZeneca is global pharma company with strong connection to Sweden through both big research and manufacturing sites. Their development of ATMPs includes CAR-T and TCR-T treatments, as well as drug delivery platforms. Their research as well as product development is spread out globally with over 80 000 employees over the world.
Synergon
Synergon offers strategic IP advice and practical management of patents, trademarks, and trade secrets. Our strength lies in pharmaceuticals, biotechnology, and medical technology, as well as digital innovations. We ensure that you receive cost-effective and commercially relevant IP protection for your business.
Drug Development
(CB2090) The lectures will cover a broad range of aspects of drug development. It will give current examples from the pharmaceutical industry and will mainly be given by invited guest lecturers.
CCRM Nordic
CCRM Nordic, based in Gothenburg, Sweden, supports academic, small, and large industrial ATMP developers to translate research and early-stage clinical programs into treatments for patients.